CytCD79a expression in acute leukemia with t(8;21): biphenotypic or myeloid leukemia?
He
Guangsheng
G
Wu
Depei
D
Sun
Aining
A
Xue
Yongquan
Y
Jin
Zhengming
Z
Qiu
Huiying
H
Miao
Miao
M
Tang
Xiaowen
X
Fu
Zhengzheng
Z
Chen
Zixin
Z
D000970:Antineoplastic Agents / Q000627:therapeutic use; D051925:CD79 Antigens / Q000235:genetics* / Q000378:metabolism*; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D050676:Core Binding Factor Alpha 2 Subunit / Q000235:genetics; D003593:Cytoplasm / Q000378:metabolism*; D006412:Hematopoietic Stem Cells; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D000075142:RUNX1 Translocation Partner 1 Protein; D014178:Translocation, Genetic
C107844:AML1-ETO fusion protein, human; D000970:Antineoplastic Agents; D051925:CD79 Antigens; D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; D000075142:RUNX1 Translocation Partner 1 Protein